Fundz

Enable Injections Announces $215 Million Financing

PRIVATEJan 27, 2022

Amount Raised

$215 Million

Round Type

Funding Round

CincinnatiManufacturingHealthcareHealth CareScience And Engineering

Description

Enable Injections, Inc. ("Enable"), a company developing and manufacturing the enFuse® platform of investigational wearable drug delivery systems, is pleased to announce $215 million in Series C financing. Magnetar Capital ("Magnetar") led the financing along with new institutional investments from GCM Grosvenor, Squarepoint Capital, Woody Creek Capital Partners, and other investors. Enable received significant continued support from existing investors including Cincinnati Children's Hospital Medical Center, CincyTech, Cintrifuse, and Ohio Innovation Fund.

Quick answer

Enable Injections raised $215 Million in a Funding Round round, dated January 27, 2022. Enable Injections is based in Cincinnati, Ohio, United States.

How much did Enable Injections raise?
Enable Injections raised $215 Million in a Funding Round round on January 27, 2022.
What does Enable Injections do?
Enable Injections is a Cincinnati-based global healthcare innovation company that develops and manufactures advanced drug delivery systems designed to improve the patient experience.
Where is Enable Injections based and how big is it?
Enable Injections is based in Cincinnati, Ohio, United States.
Who are the decision-makers at Enable Injections?
Fundz holds 1 contact at Enable Injections. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Science And Engineering around the same time

Companies in the same sectors as Enable Injections that raised within 45 days of this round, from Fundz verified event records.

  • Sherlock Biosciences raised $80M (Series B) on March 8, 2022.
  • Electra Therapeutics raised $84M (Series B) on February 16, 2022.
  • Armis Biopharma raised $7.3M on February 15, 2022.
  • Advanced NanoTherapies raised $9.2M on January 26, 2022.
  • ROM Technologies raised $1.1M on January 24, 2022.
  • Talphera, Inc. raised $5.2M on January 24, 2022.

Who to call at Enable Injections, and when

A new round usually means Enable Injections is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Enable Injections raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Enable Injections, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Enable Injections. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Enable Injections

Location

2863 EAST SHARON ROAD

Cincinnati, Ohio, United States

About

Enable Injections is a Cincinnati-based global healthcare innovation company that develops and manufactures advanced drug delivery systems designed to improve the patient experience. Its body-worn enFuse® platform enables the subcutaneous delivery of large-volume therapeutics, enhancing convenience while potentially supporting improved safety outcomes and more efficient healthcare system economics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Enable Injections raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts43 people are listed at Enable Injections. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Enable Injections's next move

See what Strategic adds

Enable Injections raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.